Evidence map›Paper›PMID 42591504›Full record

ArticleFrontiers in cell and developmental biology2026

DFN-kcr: a dual-branch deep learning model with attention-guided fusion for predicting lysine crotonylation sites in human non-histone proteins.

Xin Wei, Siqin Hu, Chen Lin

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xin WeiBusiness School, Jiangxi Institute of Fashion Technology, Nanchang, China.
Siqin HuSchool of Mega Data, Jiangxi Institute of Fashion Technology, Nanchang, China.
Chen LinSchool of Mega Data, Jiangxi Institute of Fashion Technology, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lysine crotonylation (Kcr) is extensively present in human non-histone proteins and plays a critical regulatory role in essential biological processes, including cell signaling and metabolic regulation. However, conventional wet-lab approaches for Kcr site identification are costly, time-consuming, and ill-suited for large-scale profiling. Although computational prediction methods have garnered increasing attention in recent years, there remains a notable lack of efficient and specialized tools tailored specifically for Kcr site prediction in human non-histone proteins. Methods: To address this gap, we propose DFN-Kcr, a dual-branch deep learning model explicitly designed for human non-histone Kcr site prediction. DFN-Kcr employs a dual-input strategy combining ProteinBERT embeddings and integer-encoded amino acid sequences, leveraging residual convolutional networks to capture local sequence motifs and a Transformer architecture to model long-range contextual dependencies. A branch-level gating attention fusion mechanism is further introduced to effectively integrate complementary features from both branches. Results: Extensive experiments demonstrate that DFN-Kcr significantly outperforms state-of-the-art methods, with its sensitivity (Sn), specificity (Sp), accuracy (Acc), and Matthews correlation coefficient (MCC) being 0.8244, 0.7679, 0.7961, and 0.5932, respectively. Discussion: This model offers a reliable solution for high-throughput identification of Kcr sites in non-histone proteins. To facilitate community access, we have deployed a user-friendly web server at http://www.lzzzlab.top/dfnkcr/.

Indexed as

crotonylation sitesdeep learninghuman non-histone proteinsmulti-head attention mechanismresidual transformer

Identifiers

PMID42591504
PMCPMC13462224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.